Records containing: NASH - Nonalcoholic Steatohepatitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
-
CLINICAL_TRIALS study record update · 2026-04-23Novel MRE Technique to Assess Tissue Viscoelasticity as a Risk Factor for Liver Cancer
-
CLINICAL_TRIALS study record update · 2026-04-22Prospective Multicentric, Open Label, Randomized Clinical Trial of Superiority, With Two Arms, Comparing Bariatric Surgery to the Recommended Medical Treatment for NASH
-
CLINICAL_TRIALS study record update · 2026-04-17Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis
-
CLINICAL_TRIALS study record update · 2026-04-08Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-06The GLP-1 Agonist Semaglutide for the Treatment of Metabolic Disease in Liver Transplant Recipients: A Phase IV, Randomized Trial
-
CLINICAL_TRIALS study record update · 2026-03-27A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) and Fibrosis Stages F2 and F3
-
CLINICAL_TRIALS study record update · 2026-03-18A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2026-03-10Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE
-
CLINICAL_TRIALS study record update · 2026-02-20A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
-
CLINICAL_TRIALS study record update · 2026-02-09Tocotrienol Against the Progression of End Stage Liver Disease
-
CLINICAL_TRIALS study record update · 2026-01-28Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1
-
CLINICAL_TRIALS study record update · 2026-01-20A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Statins in Adult Patients With Non-Alcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2026-01-15Nonalcoholic Fatty Liver Disease In Persons Living With HIV Database Study
-
CLINICAL_TRIALS study record update · 2026-01-08Hepatic Energy Fluxes, NASH, and Vertical Sleeve Gastrectomy
-
CLINICAL_TRIALS study record update · 2026-01-07Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
-
CLINICAL_TRIALS study record update · 2026-01-06The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease: A Pilot Study
-
CLINICAL_TRIALS study record update · 2026-01-06A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of BIO89-100 in Subjects With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2025-12-23Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"
-
CLINICAL_TRIALS study record update · 2025-12-01Non-Invasive Quantification of Liver Health in NASH (N-QUAN): A Prospective Diagnostic Accuracy Study
-
CLINICAL_TRIALS study record update · 2025-11-19A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
-
CLINICAL_TRIALS study record update · 2025-08-27The Franciscus Obesity NASH Study
-
CLINICAL_TRIALS study record update · 2025-08-03Estrogen Administration for the Treatment of NASH in Postmenopausal Women
-
CLINICAL_TRIALS study record update · 2025-08-01Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach
-
CLINICAL_TRIALS study record update · 2025-07-25Efficacy of a Novel Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD